speb/financial-data huggingface dataset:
Financial ratios for CRIS — annual report dated 2023-12-31
Total revenue: 10023000
Gross profit: 9811000
Operating income: -48332000
Net income: -47413000
Capital expenditures: 0
Operating cash flow: -38434000
Depreciation & amortization: 255000
Net tangible assets: 10688000
Owner earnings: -47158000
Return on net tangible assets (%): -441.2238023952096
Buffett classification: The Gruesome
Stock price: 255
Shares outstanding: 1948934
Book value: 19670000
P/B ratio: 25.265794102694457
Market cap (USD): 496978170
Debt to equity: 0.142043721403152
Current ratio: 2.7659052722401345
Quick ratio: 2.7659052722401345
Interest coverage ratio: -23.93858345715701
COGS to revenue (%): 2.11513518906515
R&D to revenue (%): 394.05367654394894
SG&A to revenue (%): 186.04210316272574
Free cash flow (dilution-adjusted): -44434000
Buyback yield (%): 0
Retained earnings: -1196410000
Receivables turnover: 3.587329992841804
Capitalized R&D asset: 68491590
ROCI (R&D-adjusted, %): -29.435343535032278
Rosenberg metric: -0.002172054440002773
FCF margin (%): -443.3203631647212
Revenue growth (%): -1.3678409761857901
Rule of 40 score: -444.688204140907
Financial ratios for CRIS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 107.8
Shares outstanding: 1948934
Market cap (USD): 210095085.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRIS — annual report dated 2024-12-31
Total revenue: 10908000
Gross profit: 10810000
Operating income: -44542000
Net income: -43389000
Capital expenditures: 0
Operating cash flow: -39563000
Depreciation & amortization: 203000
Net tangible assets: -14980000
Owner earnings: -43186000
Buffett classification: The Gruesome
Stock price: 61.2
Shares outstanding: 1948934
Book value: -5998000
Market cap (USD): 119274760.80000001
Debt to equity: -0.4924974991663888
Current ratio: 1.386713617490934
Quick ratio: 1.386713617490934
Interest coverage ratio: -72.4260162601626
COGS to revenue (%): 0.8984231756508985
R&D to revenue (%): 353.52035203520353
SG&A to revenue (%): 153.9237257059039
Free cash flow (dilution-adjusted): -45490000
Buyback yield (%): 0
Retained earnings: -1239799000
Receivables turnover: 3.257091669154972
Capitalized R&D asset: 79305730
ROCI (R&D-adjusted, %): -45.71921870508401
Rosenberg metric: 0.025293700627911687
FCF margin (%): -417.0333700036671
Revenue growth (%): 8.829691709069142
Rule of 40 score: -408.2036782945979
Financial ratios for CRIS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.2
Shares outstanding: 1948934
Market cap (USD): 119274760.80000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRIS — quarterly report dated 2025-03-31
Total revenue: 2380000
Gross profit: 2366000
Operating income: -10157000
Net income: -10616000
Capital expenditures: 0
Operating cash flow: -7252000
Depreciation & amortization: 59000
Net tangible assets: -15589000
Owner earnings: -10557000
Buffett classification: The Gruesome
Stock price: 42
Shares outstanding: 1948934
Book value: -6607000
Market cap (USD): 81855228
Debt to equity: -0.3994248524292417
Current ratio: 1.2333349903067057
Quick ratio: 1.2333349903067057
COGS to revenue (%): 0.5882352941176471
R&D to revenue (%): 358.78151260504205
SG&A to revenue (%): 167.39495798319328
Free cash flow (dilution-adjusted): -8416000
Buyback yield (%): 0
Retained earnings: -1250415000
Receivables turnover: 1.0280777537796977
Capitalized R&D asset: 8539000
ROCI (R&D-adjusted, %): -16.088847244245834
FCF margin (%): -353.61344537815125
Rule of 40 score: -353.61344537815125
Financial ratios for CRIS — quarterly report dated 2025-06-30
Total revenue: 2749000
Gross profit: 2733000
Operating income: -8251000
Net income: -8593000
Capital expenditures: 0
Operating cash flow: -8009000
Depreciation & amortization: 42000
Net tangible assets: -22968000
Owner earnings: -8551000
Buffett classification: The Gruesome
Stock price: 46.4
Shares outstanding: 1948934
Book value: -13986000
Market cap (USD): 90430537.6
Debt to equity: -0.1650936650936651
Current ratio: 0.7443217014247367
Quick ratio: 0.7443217014247367
COGS to revenue (%): 0.5820298290287377
R&D to revenue (%): 271.2986540560204
SG&A to revenue (%): 128.2648235722081
Free cash flow (dilution-adjusted): -9144000
Buyback yield (%): 0
Retained earnings: -1259008000
Receivables turnover: 0.9989098837209303
Capitalized R&D asset: 13179130
ROCI (R&D-adjusted, %): -26.58434431528893
Rosenberg metric: 0.04297927157746809
FCF margin (%): -332.6300472899236
Revenue growth (%): 15.504201680672269
Rule of 40 score: -317.1258456092513
Financial ratios for CRIS — quarterly report dated 2025-09-30
Total revenue: 3176000
Gross profit: 3161000
Operating income: -6924000
Net income: -7729000
Capital expenditures: 0
Operating cash flow: -5569000
Depreciation & amortization: 32000
Net tangible assets: -23673000
Owner earnings: -7697000
Buffett classification: The Gruesome
Stock price: 33.2
Shares outstanding: 1948934
Book value: -14691000
Market cap (USD): 64704608.800000004
Debt to equity: -0.13395956708188686
Current ratio: 0.6984230614704701
Quick ratio: 0.6984230614704701
COGS to revenue (%): 0.4722921914357683
R&D to revenue (%): 202.51889168765743
SG&A to revenue (%): 115.01889168765742
Free cash flow (dilution-adjusted): -6493000
Buyback yield (%): 0
Retained earnings: -1266737000
Receivables turnover: 0.9793401171754548
Capitalized R&D asset: 14246730
ROCI (R&D-adjusted, %): -36.25969800927356
Rosenberg metric: 0.05738803968892464
FCF margin (%): -204.43954659949623
Revenue growth (%): 15.532921062204439
Rule of 40 score: -188.90662553729177
Financial ratios for CRIS — annual report dated 2025-12-31
Total revenue: 9443000
Gross profit: 9398000
Operating income: -32902000
Net income: -7582000
Capital expenditures: 0
Operating cash flow: -27201000
Depreciation & amortization: 169000
Net tangible assets: -3520000
Owner earnings: -7413000
Buffett classification: The Gruesome
Stock price: 19.8
Shares outstanding: 1948934
Book value: 5462000
P/B ratio: 7.06497495422922
Market cap (USD): 38588893.2
Debt to equity: 0.29622848773343097
Current ratio: 0.4912617220801364
Quick ratio: 0.4912617220801364
Interest coverage ratio: -15.05812356979405
COGS to revenue (%): 0.47654347135444247
R&D to revenue (%): 299.2057608810759
SG&A to revenue (%): 148.74510219209998
Free cash flow (dilution-adjusted): -31219000
Buyback yield (%): 0
Retained earnings: -1247381000
Capitalized R&D asset: 67124220
ROCI (R&D-adjusted, %): -54.900721165457
Rosenberg metric: -0.03661635807271407
FCF margin (%): -330.60468071587417
Revenue growth (%): -13.430509717638431
Rule of 40 score: -344.0351904335126
Financial ratios for CRIS — quarterly report dated 2025-12-31
Total revenue: 1138000
Gross profit: 1138000
Operating income: -7570000
Net income: 19356000
Capital expenditures: 0
Operating cash flow: -6371000
Depreciation & amortization: 36000
Net tangible assets: -3520000
Owner earnings: 19392000
Return on net tangible assets (%): -550.9090909090909
Buffett classification: The Gruesome
Stock price: 19.8
P/E ratio: 0.49840996590204595
Shares outstanding: 1948934
Book value: 5462000
P/B ratio: 7.06497495422922
Market cap (USD): 38588893.2
Debt to equity: 0.29622848773343097
Current ratio: 0.4912617220801364
Quick ratio: 0.4912617220801364
COGS to revenue (%): 0
R&D to revenue (%): 511.8629173989455
SG&A to revenue (%): 253.33919156414763
Free cash flow (dilution-adjusted): -7166000
Buyback yield (%): 0
Retained earnings: -1247381000
Capitalized R&D asset: 12595580
ROCI (R&D-adjusted, %): -44.99002285384969
Rosenberg metric: -0.31452114427860695
FCF margin (%): -629.701230228471
Revenue growth (%): -64.16876574307305
Rule of 40 score: -693.8699959715441
Financial ratios for CVS.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 87.7840909090909
Shares outstanding: 1275927307
Market cap (USD): 112006118711.07954
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS.DE — annual report dated 2022-12-31
Total revenue: 322467000000
Gross profit: 54502000000
Operating income: 16290000000
Net income: 4327000000
Capital expenditures: 2727000000
Operating cash flow: 16177000000
Depreciation & amortization: 4224000000
Net tangible assets: -31484000000
Owner earnings: 5824000000
Return on net tangible assets (%): -18.498284843094908
Capex to operating income (%): 16.740331491712706
Buffett classification: The Great
Stock price: 80.47872340425533
P/E ratio: 23.731222746473165
Shares outstanding: 1275927307
Book value: 71769000000
P/B ratio: 1.4307709571540552
Market cap (USD): 102685000823.98938
Debt to equity: 0.9855508645794145
Current ratio: 0.9454343786462309
Quick ratio: 0.6704455424151193
Effective tax rate (%): 25.85675119945168
Interest coverage ratio: 7.122868386532575
COGS to revenue (%): 83.0984255753302
Free cash flow (dilution-adjusted): 13003000000
Buyback yield (%): 3.408482224194837
Retained earnings: 56398000000
Inventory turnover: 14.036930330015714
Receivables turnover: 11.822371315442147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.25469928361892
FCF margin (%): 4.032350597115364
Rule of 40 score: 4.032350597115364
Financial ratios for CVS.DE — annual report dated 2023-12-31
Total revenue: 357776000000
Gross profit: 54431000000
Operating income: 14599000000
Net income: 8368000000
Capital expenditures: 3031000000
Operating cash flow: 13426000000
Depreciation & amortization: 4366000000
Net tangible assets: -44045000000
Owner earnings: 9703000000
Return on net tangible assets (%): -22.029742309002156
Capex to operating income (%): 20.761696006575793
Buffett classification: The Great
Stock price: 71.06666666666666
P/E ratio: 10.83603018851179
Shares outstanding: 1275927307
Book value: 76636000000
P/B ratio: 1.1832024194564783
Market cap (USD): 90675900617.46666
Debt to equity: 1.0358708700871653
Current ratio: 0.8569119448408239
Quick ratio: 0.6292919471138668
Effective tax rate (%): 25.10516423520988
Interest coverage ratio: 5.492475545522949
COGS to revenue (%): 84.78629086355708
Free cash flow (dilution-adjusted): 9807000000
Buyback yield (%): 2.218891663936155
Retained earnings: 61604000000
Inventory turnover: 16.829126213592232
Receivables turnover: 10.1563005649076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.560505221679499
FCF margin (%): 2.7411005768972765
Revenue growth (%): 10.949647560835682
Rule of 40 score: 13.690748137732959
Financial ratios for CVS.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.06666666666666
Shares outstanding: 1275927307
Market cap (USD): 74088845626.46666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.416666666666664
Shares outstanding: 1275927307
Market cap (USD): 52844655964.916664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVS.DE — annual report dated 2024-12-31
Total revenue: 372809000000
Gross profit: 51401000000
Operating income: 9695000000
Net income: 4614000000
Capital expenditures: 2781000000
Operating cash flow: 9107000000
Depreciation & amortization: 4597000000
Net tangible assets: -43035000000
Owner earnings: 6430000000
Return on net tangible assets (%): -14.941326827001278
Capex to operating income (%): 28.684889118102113
Buffett classification: The Good
Stock price: 41.416666666666664
P/E ratio: 11.453111392483022
Shares outstanding: 1275927307
Book value: 75730000000
P/B ratio: 0.6978034591960472
Market cap (USD): 52844655964.916664
Debt to equity: 1.0949425590915094
Current ratio: 0.811320308714203
Quick ratio: 0.5973123426585825
Effective tax rate (%): 25.406636304489265
Interest coverage ratio: 3.277552400270453
COGS to revenue (%): 86.21251096405935
Free cash flow (dilution-adjusted): 5786000000
Buyback yield (%): 5.720540601129008
Retained earnings: 62837000000
Inventory turnover: 17.750483238526538
Receivables turnover: 10.22262743700129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.75009193029904
FCF margin (%): 1.5520011587703086
Revenue growth (%): 4.201791064800322
Rule of 40 score: 5.75379222357063
Financial ratios for CVS.DE — quarterly report dated 2025-03-31
Total revenue: 94588000000
Gross profit: 14396000000
Operating income: 3374000000
Net income: 1782000000
Capital expenditures: 743000000
Operating cash flow: 4556000000
Depreciation & amortization: 1154000000
Net tangible assets: -40844000000
Owner earnings: 2193000000
Return on net tangible assets (%): -5.36920967583978
Capex to operating income (%): 22.021339656194428
Buffett classification: The Great
Stock price: 64.69565217391305
P/E ratio: 11.580660669594495
Shares outstanding: 1275927307
Book value: 77110000000
P/B ratio: 1.0705090034090206
Market cap (USD): 82546949252.86957
Debt to equity: 1.0532097004279601
Current ratio: 0.822731309225391
Quick ratio: 0.6273085959015748
Effective tax rate (%): 31.9067634696217
Interest coverage ratio: 4.298089171974523
COGS to revenue (%): 84.78031039878209
Free cash flow (dilution-adjusted): 3687000000
Buyback yield (%): 0
Retained earnings: 63768000000
Inventory turnover: 4.612712108139201
Receivables turnover: 2.3870788643533123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.024918379105051
FCF margin (%): 3.8979574576056155
Rule of 40 score: 3.8979574576056155
Financial ratios for CVS.DE — quarterly report dated 2025-06-30
Total revenue: 98915000000
Gross profit: 13593000000
Operating income: 2381000000
Net income: 1021000000
Capital expenditures: 607000000
Operating cash flow: 1897000000
Depreciation & amortization: 1171000000
Net tangible assets: -40048000000
Owner earnings: 1585000000
Return on net tangible assets (%): -3.957750699161007
Capex to operating income (%): 25.493490130197394
Buffett classification: The Good
Stock price: 66.08235294117648
P/E ratio: 30.080727302339934
Shares outstanding: 1275927307
Book value: 77551000000
P/B ratio: 1.0872365105344721
Market cap (USD): 84316278628.45883
Debt to equity: 1.066704491238024
Current ratio: 0.8033920265075083
Quick ratio: 0.6181049680338141
Effective tax rate (%): 38.49423193685489
Interest coverage ratio: 3.1205766710353866
COGS to revenue (%): 86.25789819542031
Free cash flow (dilution-adjusted): 1154000000
Buyback yield (%): 0
Retained earnings: 63936000000
Inventory turnover: 4.890353642460021
Receivables turnover: 2.4332734742072764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4502287109957912
FCF margin (%): 1.166658241924885
Revenue growth (%): 4.574576056159343
Rule of 40 score: 5.741234298084228
Financial ratios for CVS.DE — quarterly report dated 2025-09-30
Total revenue: 102871000000
Gross profit: 13806000000
Operating income: 2518000000
Net income: -3975000000
Capital expenditures: 698000000
Operating cash flow: 796000000
Depreciation & amortization: 1134000000
Net tangible assets: -38534000000
Owner earnings: -3539000000
Capex to operating income (%): 27.720413026211276
Buffett classification: The Good
Stock price: 72.74117647058823
Shares outstanding: 1275927307
Book value: 73110000000
P/B ratio: 1.2694905403108934
Market cap (USD): 92812453402.12941
Debt to equity: 1.1182054438517304
Current ratio: 0.8318571659744323
Quick ratio: 0.6272938130427747
Interest coverage ratio: 3.211734693877551
COGS to revenue (%): 86.57930806544118
Free cash flow (dilution-adjusted): -40000000
Buyback yield (%): 0
Retained earnings: 59107000000
Inventory turnover: 4.697025630207784
Receivables turnover: 2.345600474268646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5482807811500812
FCF margin (%): -0.03888365039709928
Revenue growth (%): 3.99939341859172
Rule of 40 score: 3.960509768194621
Financial ratios for CVS.DE — quarterly report dated 2025-12-31
Total revenue: 105693000000
Gross profit: 13567000000
Operating income: 2112000000
Net income: 2943000000
Capital expenditures: 784000000
Operating cash flow: 3390000000
Depreciation & amortization: 1147000000
Net tangible assets: -35772000000
Owner earnings: 3306000000
Return on net tangible assets (%): -9.241865145924187
Capex to operating income (%): 37.121212121212125
Buffett classification: The Good
Stock price: 78.54117647058824
P/E ratio: 56.585449905550206
Shares outstanding: 1275927307
Book value: 75382000000
P/B ratio: 1.3294000130366588
Market cap (USD): 100212831782.72942
Debt to equity: 1.0605980207476586
Current ratio: 0.8423984124836513
Quick ratio: 0.6254002615793983
Effective tax rate (%): -115.87887740029541
Interest coverage ratio: 2.6836086404066073
COGS to revenue (%): 87.16376675844191
Free cash flow (dilution-adjusted): 2471000000
Buyback yield (%): 0
Retained earnings: 61196000000
Inventory turnover: 4.78676088537878
Receivables turnover: 2.657004952361799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2811957827305485
FCF margin (%): 2.3379031723955226
Revenue growth (%): 2.743241535515354
Rule of 40 score: 5.081144707910877
Financial ratios for CVS.DE — annual report dated 2025-12-31
Total revenue: 402067000000
Gross profit: 55362000000
Operating income: 10385000000
Net income: 1768000000
Capital expenditures: 2832000000
Operating cash flow: 10639000000
Depreciation & amortization: 4606000000
Net tangible assets: -35772000000
Owner earnings: 3542000000
Return on net tangible assets (%): -9.901599015990161
Capex to operating income (%): 27.270101107366397
Buffett classification: The Good
Stock price: 78.54117647058824
P/E ratio: 56.68146594045782
Shares outstanding: 1275927307
Book value: 75382000000
P/B ratio: 1.3294000130366588
Market cap (USD): 100212831782.72942
Debt to equity: 1.0605980207476586
Current ratio: 0.8423984124836513
Quick ratio: 0.6254002615793983
Effective tax rate (%): 19.101123595505616
Interest coverage ratio: 3.329592818210965
COGS to revenue (%): 86.2306531001052
Free cash flow (dilution-adjusted): 7272000000
Buyback yield (%): 0
Retained earnings: 61196000000
Inventory turnover: 18.01439260105996
Receivables turnover: 10.107519042710978
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.299819225216262
FCF margin (%): 1.8086537815836665
Revenue growth (%): 7.847986502471775
Rule of 40 score: 9.656640284055442
Financial ratios for ECLERX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.406171699854939
Shares outstanding: 92025272
Market cap (USD): 957630781.1578531
Buyback yield (%): 0
Retained earnings: 195112356.58710274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECLERX.NS — annual report dated 2023-03-31
Total revenue: 322619488.42874545
Gross profit: 133157125.45676006
Operating income: 74506455.54202193
Net income: 59583556.638246045
Capital expenditures: 10969183.922046285
Operating cash flow: 59996833.13032887
Depreciation & amortization: 13887210.71863581
Net tangible assets: 146330450.66991475
Owner earnings: 62501583.43483557
Return on net tangible assets (%): 42.712629632928326
Capex to operating income (%): 14.722461083737398
Buffett classification: The Great
Stock price: 7.849330085261876
P/E ratio: 12.123088598077194
Shares outstanding: 92025272
Book value: 209080876.97929358
P/B ratio: 3.4548197164178926
Market cap (USD): 722336736.1140074
Debt to equity: 0.11275963354488118
Current ratio: 3.915623813317116
Quick ratio: 3.914327563020892
Effective tax rate (%): 25.08598906568248
Interest coverage ratio: 28.90549097438805
COGS to revenue (%): 58.72626104973523
SG&A to revenue (%): 4.607419623015918
Free cash flow (dilution-adjusted): 48035931.7904994
Buyback yield (%): 5.633732419361886
Retained earnings: 193234226.55298418
Inventory turnover: 3426.180616740088
Receivables turnover: 6.013130921003344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.57146079257684
FCF margin (%): 14.889345967427115
Rule of 40 score: 14.889345967427115
Financial ratios for ECLERX.NS — annual report dated 2024-03-31
Total revenue: 350826597.9134189
Gross profit: 134469480.7530879
Operating income: 77829475.95634969
Net income: 61365991.1260343
Capital expenditures: 7704760.762681376
Operating cash flow: 63064156.37366591
Depreciation & amortization: 17780549.226525962
Net tangible assets: 211851061.27833074
Owner earnings: 71441779.58987887
Return on net tangible assets (%): 33.72264418162077
Capex to operating income (%): 9.899540846198883
Buffett classification: The Great
Stock price: 14.190858925143955
P/E ratio: 21.28080437612242
Shares outstanding: 92025272
Book value: 269752967.98177236
P/B ratio: 4.8411613865477205
Market cap (USD): 1305917652.5
Debt to equity: 0.11813449390300827
Current ratio: 5.322572302680812
Quick ratio: 5.320797750583264
Effective tax rate (%): 25.76464887950144
Interest coverage ratio: 27.63668880940215
COGS to revenue (%): 61.670671051493684
SG&A to revenue (%): 3.9402257973989783
Free cash flow (dilution-adjusted): 52722988.36790983
Buyback yield (%): 0.4211643780676841
Retained earnings: 248091497.78150856
Inventory turnover: 2797.212403100775
Receivables turnover: 5.898284069121107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.4261291850452
FCF margin (%): 15.02821869307681
Revenue growth (%): 8.7431511413184
Rule of 40 score: 23.77136983439521
Financial ratios for ECLERX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 187086956.52173913
Buffett classification: The Gruesome
Stock price: 17.960463449593885
Shares outstanding: 92025272
Book value: 244845676.06306735
P/B ratio: 6.750441995835789
Market cap (USD): 1652816534.1949356
Debt to equity: 0.14133291834321376
Current ratio: 5.267296773429563
Quick ratio: 5.266383710711814
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECLERX.NS — quarterly report dated 2024-12-31
Total revenue: 99524536.6592843
Gross profit: 35988343.62979368
Operating income: 20014104.207949642
Net income: 15992423.359365892
Capital expenditures: 0
Depreciation & amortization: 4170649.2598204915
Owner earnings: 20163072.619186383
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.296771185452847
P/E ratio: 29.198449901733976
Shares outstanding: 92025272
Market cap (USD): 1867815889.0630608
Effective tax rate (%): 25.434920841961095
Interest coverage ratio: 20.74435181829165
COGS to revenue (%): 63.83972753071194
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECLERX.NS — quarterly report dated 2025-03-31
Total revenue: 105013560.90717793
Gross profit: 39006546.64484452
Operating income: 20764905.307458498
Net income: 17829904.138414774
Capital expenditures: 0
Depreciation & amortization: 4788636.895019873
Net tangible assets: 213547112.46200606
Owner earnings: 22618541.033434648
Return on net tangible assets (%): 10.591827148896195
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.199673240751547
P/E ratio: 20.902795168138034
Shares outstanding: 92025272
Book value: 269810498.01262563
P/B ratio: 5.525282919945993
Market cap (USD): 1490779336.2912827
Debt to equity: 0.15517043413682827
Current ratio: 4.557069502651362
Quick ratio: 4.5565544328900405
Effective tax rate (%): 23.266519757297672
Interest coverage ratio: 16.475558853538633
COGS to revenue (%): 62.855705198567044
Buyback yield (%): 0
Inventory turnover: 2487.330396475771
Receivables turnover: 1.813177075658884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.566576313995497
Revenue growth (%): 5.515247226605982
Rule of 40 score: 5.515247226605982
Financial ratios for ECLERX.NS — annual report dated 2025-03-31
Total revenue: 393484334.814122
Gross profit: 142468786.53261632
Operating income: 77962824.40963292
Net income: 63275543.60533083
Capital expenditures: 13459551.08721066
Operating cash flow: 76527589.43184474
Depreciation & amortization: 16506079.027355623
Net tangible assets: 213547112.46200606
Owner earnings: 66322071.54547579
Return on net tangible assets (%): 31.057348788678045
Capex to operating income (%): 17.264062954532502
Buffett classification: The Great
Stock price: 16.199673240751547
P/E ratio: 23.560118986724714
Shares outstanding: 92025272
Book value: 269810498.01262563
P/B ratio: 5.525282919945993
Market cap (USD): 1490779336.2912827
Debt to equity: 0.15517043413682827
Current ratio: 4.557069502651362
Quick ratio: 4.5565544328900405
Effective tax rate (%): 24.671447717635008
Interest coverage ratio: 19.114187446259674
COGS to revenue (%): 63.79302200177369
Free cash flow (dilution-adjusted): 57587912.08791208
Buyback yield (%): 3.735228019755685
Retained earnings: 249248071.0778583
Inventory turnover: 9458.97356828194
Receivables turnover: 6.7939489848028245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.654523031058552
FCF margin (%): 14.635376047464769
Revenue growth (%): 12.159208325256659
Rule of 40 score: 26.794584372721427
Financial ratios for ECLERX.NS — quarterly report dated 2025-06-30
Total revenue: 109355956.00280833
Gross profit: 38776737.6550433
Operating income: 21488181.60542944
Net income: 16578282.237304004
Capital expenditures: 0
Depreciation & amortization: 4317575.473905921
Owner earnings: 20895857.711209923
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.479288556049617
P/E ratio: 37.39264484383896
Shares outstanding: 92025272
Market cap (USD): 1884612099.7369533
Effective tax rate (%): 24.729867698983284
Interest coverage ratio: 18.947379281881965
COGS to revenue (%): 64.54080868348179
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.135080324976957
Rule of 40 score: 4.135080324976957
Financial ratios for ECLERX.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.63641488162345
P/E ratio: 41.33129038588101
Shares outstanding: 92025272
Market cap (USD): 2083122236.5862455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECLERX.NS — quarterly report dated 2025-12-31
Total revenue: 119230477.88793585
Gross profit: 43740447.811072744
Operating income: 25615907.318703353
Net income: 21385318.034978278
Capital expenditures: 0
Depreciation & amortization: 5158627.603876574
Owner earnings: 26543945.638854854
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.151832460732987
P/E ratio: 43.13458207934272
Shares outstanding: 92025272
Market cap (USD): 2406629495.4973826
Effective tax rate (%): 23.312076444835377
Interest coverage ratio: 23.2065798768796
COGS to revenue (%): 63.31437348411521
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDT.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1732283464566929
Shares outstanding: 293418991
Market cap (USD): 50828486.62992126
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDT.TO — annual report dated 2022-12-31
Total revenue: 1225735.294117647
Gross profit: 722794.1176470588
Operating income: -4450735.294117646
Net income: -7013970.5882352935
Capital expenditures: 24264.70588235294
Operating cash flow: -7279411.7647058815
Depreciation & amortization: 200000
Net tangible assets: -2033088.2352941176
Owner earnings: -6838235.294117646
Buffett classification: The Gruesome
Stock price: 0.27205882352941174
Shares outstanding: 293418991
Book value: -1877941.176470589
Market cap (USD): 79827225.49264705
Debt to equity: -1.5982772122161308
Current ratio: 0.9967388081826267
Quick ratio: 0.9631386500642356
Interest coverage ratio: -34.392045454545446
COGS to revenue (%): 41.03179364127175
SG&A to revenue (%): 359.74805038992196
Free cash flow (dilution-adjusted): -8183823.529411765
Buyback yield (%): 0
Retained earnings: -80716911.76470588
Inventory turnover: 2.011764705882353
Receivables turnover: 1.5785984848484849
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -322.4826851358552
FCF margin (%): -667.6664667066588
Rule of 40 score: -667.6664667066588
Financial ratios for EDT.TO — annual report dated 2023-12-31
Total revenue: 1210606.0606060605
Gross profit: 501515.1515151515
Operating income: -6397727.2727272725
Net income: -11865151.515151514
Capital expenditures: 140151.51515151514
Operating cash flow: -8121969.696969696
Depreciation & amortization: 165151.51515151514
Net tangible assets: -12683333.333333332
Owner earnings: -11840151.515151514
Buffett classification: The Gruesome
Stock price: 0.32575757575757575
Shares outstanding: 293418991
Book value: -12537121.212121211
Market cap (USD): 95583459.18939394
Debt to equity: -0.5173122243035834
Current ratio: 0.23021542582877555
Quick ratio: 0.20978903895524056
Interest coverage ratio: -6.330584707646177
COGS to revenue (%): 58.57321652065082
SG&A to revenue (%): 501.8147684605758
Free cash flow (dilution-adjusted): -9389393.93939394
Buyback yield (%): 0
Retained earnings: -95028030.3030303
Inventory turnover: 2.557377049180328
Receivables turnover: 8.591397849462364
Capitalized R&D asset: 0
FCF margin (%): -775.5944931163955
Revenue growth (%): -1.2342985948264884
Rule of 40 score: -776.8287917112219
Financial ratios for EDT.TO — quarterly report dated 2024-09-30
Capital expenditures: 2962.9629629629626
Buffett classification: The Gruesome
Stock price: 0.45185185185185184
Shares outstanding: 293418991
Market cap (USD): 132581914.45185184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDT.TO — annual report dated 2024-12-31
Total revenue: 1598601.3986013986
Gross profit: 498601.3986013986
Operating income: -8389510.48951049
Net income: -10770629.37062937
Capital expenditures: 18881.11888111888
Operating cash flow: -6166433.566433567
Depreciation & amortization: 175524.47552447554
Net tangible assets: -19384615.384615384
Owner earnings: -10613986.013986014
Buffett classification: The Gruesome
Stock price: 0.3496503496503497
Shares outstanding: 293418991
Book value: -19262237.762237765
Market cap (USD): 102594052.79720281
Debt to equity: -0.5418406244327464
Current ratio: 0.1624339588267444
Quick ratio: 0.15408999817817454
Interest coverage ratio: -3.7762039660056654
COGS to revenue (%): 68.81014873140857
SG&A to revenue (%): 497.9440069991251
Free cash flow (dilution-adjusted): -7356643.356643357
Buyback yield (%): 0
Retained earnings: -98488811.1888112
Inventory turnover: 6.868995633187772
Receivables turnover: 5.068736141906873
Capitalized R&D asset: 0
FCF margin (%): -460.1924759405075
Revenue growth (%): 32.04967748146722
Rule of 40 score: -428.1427984590403
Financial ratios for EDT.TO — quarterly report dated 2024-12-31
Capital expenditures: 699.3006993006993
Buffett classification: The Gruesome
Stock price: 0.3496503496503497
Shares outstanding: 293418991
Market cap (USD): 102594052.79720281
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDT.TO — quarterly report dated 2025-03-31
Total revenue: 400000
Gross profit: 411888.1118881119
Operating income: -614685.3146853147
Net income: -8814685.314685315
Capital expenditures: 0
Operating cash flow: -1002797.2027972029
Depreciation & amortization: 41958.04195804196
Net tangible assets: -27207692.307692308
Owner earnings: -8772727.272727273
Buffett classification: The Gruesome
Stock price: 0.5384615384615385
Shares outstanding: 293418991
Book value: -27088111.88811189
Market cap (USD): 157994841.30769232
Debt to equity: -0.39454254440313924
Current ratio: 0.08685921347117127
Quick ratio: 0.08150378343813279
Interest coverage ratio: -0.8116343490304709
COGS to revenue (%): -2.9720279720279725
SG&A to revenue (%): 213.46153846153845
Free cash flow (dilution-adjusted): -1883916.083916084
Buyback yield (%): 0
Retained earnings: -107303496.50349651
Inventory turnover: -0.0845771144278607
Receivables turnover: 1.8451612903225805
Capitalized R&D asset: 0
FCF margin (%): -470.979020979021
Rule of 40 score: -470.979020979021
Financial ratios for EDT.TO — quarterly report dated 2025-06-30
Total revenue: 593430.6569343065
Gross profit: 381021.897810219
Operating income: -1374452.5547445253
Net income: -1410948.9051094889
Capital expenditures: 0
Operating cash flow: -1983941.605839416
Depreciation & amortization: 41605.83941605839
Net tangible assets: -29569343.065693427
Owner earnings: -1369343.0656934304
Buffett classification: The Gruesome
Stock price: 0.5912408759124087
Shares outstanding: 293418991
Book value: -29325547.445255473
Market cap (USD): 173481301.24817517
Debt to equity: -0.43797291915571485
Current ratio: 0.11968043444206568
Quick ratio: 0.11331000992115293
Interest coverage ratio: -1.6025531914893616
COGS to revenue (%): 35.79335793357934
SG&A to revenue (%): 263.8376383763838
Free cash flow (dilution-adjusted): -2329927.00729927
Buyback yield (%): 0
Retained earnings: -113414598.54014598
Inventory turnover: 1.1926229508196722
Receivables turnover: 2.656862745098039
Capitalized R&D asset: 0
FCF margin (%): -392.61992619926207
Revenue growth (%): 48.35766423357663
Rule of 40 score: -344.2622619656854
Financial ratios for EDT.TO — quarterly report dated 2025-09-30
Total revenue: 485611.5107913669
Gross profit: 465467.6258992806
Operating income: -1536690.6474820145
Net income: -21810071.942446046
Capital expenditures: 0
Operating cash flow: -1917266.1870503598
Depreciation & amortization: 49640.287769784176
Net tangible assets: -49648201.43884893
Owner earnings: -21760431.654676262
Buffett classification: The Gruesome
Stock price: 1.050359712230216
Shares outstanding: 293418991
Book value: -49398561.15107914
Market cap (USD): 308195486.94964033
Debt to equity: -0.3051963183036234
Current ratio: 0.10767563716249313
Quick ratio: 0.10443972747109205
Interest coverage ratio: -1.565982404692082
COGS to revenue (%): 4.148148148148148
SG&A to revenue (%): 336.8888888888889
Free cash flow (dilution-adjusted): -2179136.6906474824
Buyback yield (%): 0
Retained earnings: -133592805.7553957
Inventory turnover: 0.12844036697247704
Receivables turnover: 1.5588914549653579
Capitalized R&D asset: 0
FCF margin (%): -448.7407407407408
Revenue growth (%): -18.168786004406794
Rule of 40 score: -466.9095267451476
Financial ratios for EDT.TO — annual report dated 2025-12-31
Total revenue: 1782481.7518248174
Gross profit: 967883.2116788321
Operating income: -8529197.08029197
Net income: -34811678.83211678
Capital expenditures: 0
Operating cash flow: -6951824.817518247
Depreciation & amortization: 182481.7518248175
Net tangible assets: -51135036.49635036
Owner earnings: -34629197.080291964
Buffett classification: The Gruesome
Stock price: 1.0510948905109487
Shares outstanding: 293418991
Book value: -50891970.80291971
Market cap (USD): 308411202.21897805
Debt to equity: -0.309242419896159
Current ratio: 0.07987263837749743
Quick ratio: 0.0741836180358544
Interest coverage ratio: -2.2627807900852055
COGS to revenue (%): 45.7002457002457
SG&A to revenue (%): 480.30303030303037
Free cash flow (dilution-adjusted): -8640875.912408758
Buyback yield (%): 0
Retained earnings: -137613868.61313868
Inventory turnover: 2.9602122015915118
Receivables turnover: 11.912195121951218
Capitalized R&D asset: 0
FCF margin (%): -484.7665847665847
Revenue growth (%): 11.502576776443084
Rule of 40 score: -473.2640079901416
Financial ratios for EDT.TO — quarterly report dated 2025-12-31
Total revenue: 278832.1167883212
Gross profit: -401459.85401459853
Operating income: -5039416.05839416
Net income: -2070802.9197080291
Capital expenditures: 0
Operating cash flow: -1975912.4087591239
Depreciation & amortization: 46715.32846715328
Net tangible assets: -51135036.49635036
Owner earnings: -2024087.591240876
Buffett classification: The Gruesome
Stock price: 1.0510948905109487
Shares outstanding: 293418991
Book value: -50891970.80291971
Market cap (USD): 308411202.21897805
Debt to equity: -0.309242419896159
Current ratio: 0.07987263837749743
Quick ratio: 0.0741836180358544
Interest coverage ratio: -4.477302204928664
COGS to revenue (%): 243.97905759162302
SG&A to revenue (%): 1594.240837696335
Free cash flow (dilution-adjusted): -2133576.642335766
Buyback yield (%): 0
Retained earnings: -137613868.61313868
Inventory turnover: 2.4721485411140587
Receivables turnover: 1.8634146341463416
Capitalized R&D asset: 0
FCF margin (%): -765.1832460732982
Revenue growth (%): -42.58123817247905
Rule of 40 score: -807.7644842457772
Financial ratios for ENGINERSIN.NS — annual report dated 2022-03-31
Capital expenditures: 3384794.9360411447
Buffett classification: The Gruesome
Stock price: 0.7688250032968482
Shares outstanding: 562042373
Market cap (USD): 432112229.27469337
Buyback yield (%): 0
Retained earnings: 1968930.5024396677
Capitalized R&D asset: 15257.813530265066
Rule of 40 score: 0
Financial ratios for ENGINERSIN.NS — annual report dated 2023-03-31
Total revenue: 405401632.15590745
Gross profit: 182058708.89159563
Operating income: 34896906.21193667
Net income: 42176199.75639465
Capital expenditures: 4198842.87454324
Operating cash flow: -13730548.112058466
Depreciation & amortization: 3130182.7040194888
Net tangible assets: 238637892.8136419
Owner earnings: 41107539.58587089
Return on net tangible assets (%): 17.225906205085696
Capex to operating income (%): 12.032135023783296
Buffett classification: The Great
Stock price: 0.858952496954933
P/E ratio: 11.446448529531867
Shares outstanding: 562042373
Book value: 238918258.22168088
P/B ratio: 2.0206396249335143
Market cap (USD): 482767699.68282586
Debt to equity: 0.009625601874139475
Current ratio: 1.0427265837037003
Quick ratio: 1.04026426256242
Effective tax rate (%): 22.73319234269076
Interest coverage ratio: 190.5577652144995
COGS to revenue (%): 55.0917671634878
R&D to revenue (%): 0.005960916219262449
SG&A to revenue (%): 0.769781423657879
Free cash flow (dilution-adjusted): -17957490.864799026
Buyback yield (%): 0
Retained earnings: -8174738.124238734
Inventory turnover: 310.4926510430778
Receivables turnover: 9.048567903664559
Capitalized R&D asset: 34388.38670961377
ROCI (R&D-adjusted, %): 14.402506418818042
FCF margin (%): -4.4295556407363
Rule of 40 score: -4.4295556407363
Financial ratios for ENGINERSIN.NS — annual report dated 2024-03-31
Total revenue: 393592073.39009476
Gross profit: 190016200.98333132
Operating income: 31612279.64983811
Net income: 53394627.65319583
Capital expenditures: 4065403.5256025903
Operating cash flow: 26617460.127113562
Depreciation & amortization: 4197205.899988008
Net tangible assets: 269868005.7560859
Owner earnings: 53526430.027581245
Return on net tangible assets (%): 19.834300059992994
Capex to operating income (%): 12.86020360010136
Buffett classification: The Great
Stock price: 2.3295345489443378
P/E ratio: 24.521139736720215
Shares outstanding: 562042373
Book value: 270453747.4517328
P/B ratio: 4.841112900858684
Market cap (USD): 1309297125.8741603
Debt to equity: 0.014639337550277926
Current ratio: 1.1040536173256088
Quick ratio: 1.1023876618931836
Effective tax rate (%): 24.681361862130334
Interest coverage ratio: 110.06421443781052
COGS to revenue (%): 51.722553925773916
R&D to revenue (%): 0.0025745207209767044
SG&A to revenue (%): 0.9747165917318642
Free cash flow (dilution-adjusted): 22540124.715193667
Buyback yield (%): 0
Retained earnings: 3145245.233241396
Inventory turnover: 417.4439225907984
Receivables turnover: 9.77367802137297
Capitalized R&D asset: 31359.174552242537
ROCI (R&D-adjusted, %): 11.45386425561022
Rosenberg metric: 329.2893652880545
FCF margin (%): 5.726773032050833
Revenue growth (%): -2.913051608354411
Rule of 40 score: 2.8137214236964216
Financial ratios for ENGINERSIN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 284068956.04395604
Buffett classification: The Gruesome
Stock price: 2.4426660296225515
Shares outstanding: 562042373
Book value: 284525000.00000006
P/B ratio: 4.825171115844115
Market cap (USD): 1372881811.735547
Debt to equity: 0.012207544673936026
Current ratio: 1.109797925761947
Quick ratio: 1.1093540400581294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENGINERSIN.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.049306445972724
Shares outstanding: 562042373
Market cap (USD): 1151797057.8987062
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENGINERSIN.NS — quarterly report dated 2025-03-31
Total revenue: 118099240.12158054
Gross profit: 68552560.20575169
Operating income: 34923158.756137475
Net income: 32711012.391863454
Capital expenditures: 0
Depreciation & amortization: 1272118.3072246902
Net tangible assets: 311247170.91419214
Owner earnings: 33983130.69908814
Return on net tangible assets (%): 10.91837416522477
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8324191854358736
P/E ratio: 7.871181232297188
Shares outstanding: 562042373
Book value: 312050607.90273553
P/B ratio: 3.300417308060873
Market cap (USD): 1029897227.3131055
Debt to equity: 0.0082930200414651
Current ratio: 1.185260262636307
Quick ratio: 1.1836563006256358
Effective tax rate (%): 22.80412085358496
Interest coverage ratio: 593.9019880715706
COGS to revenue (%): 41.95342820565284
Buyback yield (%): 0
Retained earnings: 25132324.058919802
Inventory turnover: 102.9894780326594
Receivables turnover: 2.2722692171697405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.06491460372922
Rule of 40 score: 0
Financial ratios for ENGINERSIN.NS — annual report dated 2025-03-31
Total revenue: 360952186.11176056
Gross profit: 206986427.40238485
Operating income: 55260053.77601122
Net income: 67777799.85971475
Capital expenditures: 4789186.345569324
Operating cash flow: 13680570.49333645
Depreciation & amortization: 4624444.704231938
Net tangible assets: 311247170.91419214
Owner earnings: 67613058.21837735
Return on net tangible assets (%): 21.72326836571235
Capex to operating income (%): 8.6666335233433
Buffett classification: The Great
Stock price: 1.8324191854358736
P/E ratio: 15.195200042562135
Shares outstanding: 562042373
Book value: 312050607.90273553
P/B ratio: 3.300417308060873
Market cap (USD): 1029897227.3131055
Debt to equity: 0.0082930200414651
Current ratio: 1.185260262636307
Quick ratio: 1.1836563006256358
Effective tax rate (%): 21.457465581412862
Interest coverage ratio: 177.75816034897716
COGS to revenue (%): 42.65544430355763
R&D to revenue (%): 0.004352916599866887
SG&A to revenue (%): 1.3372587313385704
Free cash flow (dilution-adjusted): 8780734.159457562
Buyback yield (%): 0
Retained earnings: 25132324.058919802
Inventory turnover: 320.0386615474339
Receivables turnover: 6.944841817165962
Capitalized R&D asset: 30475.79602479057
ROCI (R&D-adjusted, %): 17.506381461174474
Rosenberg metric: 1674.7303918164182
FCF margin (%): 2.432658534097037
Revenue growth (%): -8.292821295205389
Rule of 40 score: -5.860162761108352
Financial ratios for ENGINERSIN.NS — quarterly report dated 2025-06-30
Total revenue: 101844055.69857244
Gross profit: 49713199.15750059
Operating income: 7200889.304937983
Net income: 7652808.3313831035
Capital expenditures: 0
Depreciation & amortization: 1234530.7746314066
Owner earnings: 8887339.10601451
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.7553241282471332
P/E ratio: 38.36626175807712
Shares outstanding: 562042373
Market cap (USD): 1548608911.424175
Effective tax rate (%): 25.198465114031997
Interest coverage ratio: 99.41647819063006
COGS to revenue (%): 51.18694084155819
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -13.764004244458938
Rule of 40 score: -13.764004244458938
Financial ratios for ENGINERSIN.NS — quarterly report dated 2025-09-30
Total revenue: 103865738.44419391
Gross profit: 49684351.74746336
Operating income: 12357192.784667417
Net income: 9412243.517474633
Capital expenditures: 0
Depreciation & amortization: 1142378.8049605412
Net tangible assets: 304395197.29425025
Owner earnings: 10554622.322435174
Return on net tangible assets (%): 3.4674076385746386
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1498308906426153
P/E ratio: 24.274640306675483
Shares outstanding: 562042373
Book value: 304991386.6967305
P/B ratio: 3.961738291733968
Market cap (USD): 1208296055.325479
Debt to equity: 0.007309353109423019
Current ratio: 1.169250200313103
Quick ratio: 1.1690155879647355
Effective tax rate (%): 25.264510381689853
Interest coverage ratio: 200.71104193371175
COGS to revenue (%): 52.16483077895961
Buyback yield (%): 0
Inventory turnover: 752.4485674025364
Receivables turnover: 1.8426272138838895
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.008531088101756
Revenue growth (%): 1.9850768233396372
Rule of 40 score: 1.9850768233396372
Financial ratios for ENGINERSIN.NS — quarterly report dated 2025-12-31
Total revenue: 134815784.7833352
Gross profit: 81801760.05346999
Operating income: 38097426.75726858
Net income: 38673042.219004124
Capital expenditures: 0
Depreciation & amortization: 1139044.224128328
Owner earnings: 39812086.44313245
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2253536816308346
P/E ratio: 14.140821926308526
Shares outstanding: 562042373
Market cap (USD): 1250743063.9880807
Effective tax rate (%): 23.725701693139946
Interest coverage ratio: 572.7693853625858
COGS to revenue (%): 39.32330684798147
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 29.798128625225594
Rule of 40 score: 29.798128625225594
Financial ratios for FERG.L — annual report dated 2021-07-31
Capital expenditures: 139000000
Buffett classification: The Gruesome
Stock price: 1.268888888888889
Shares outstanding: 193937826
Market cap (USD): 246085552.54666668
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FERG.L — annual report dated 2022-07-31
Total revenue: 28566000000
Gross profit: 8756000000
Operating income: 2820000000
Net income: 2122000000
Capital expenditures: 290000000
Operating cash flow: 1149000000
Depreciation & amortization: 301000000
Net tangible assets: 1835000000
Owner earnings: 2133000000
Return on net tangible assets (%): 116.23978201634877
Capex to operating income (%): 10.28368794326241
Buffett classification: The Great
Stock price: 1.1558536585365855
P/E ratio: 0.10563795745086321
Shares outstanding: 193937826
Book value: 4665000000
P/B ratio: 0.048052249884401224
Market cap (USD): 224163745.71073174
Debt to equity: 1.0992497320471597
Current ratio: 1.647008104845663
Quick ratio: 0.8998103121227798
Effective tax rate (%): 22.488921713441652
Interest coverage ratio: 25.405405405405407
COGS to revenue (%): 69.34817615346915
SG&A to revenue (%): 19.726247987117553
Free cash flow (dilution-adjusted): 802000000
Buyback yield (%): 689.2283116975207
Retained earnings: 7594000000
Inventory turnover: 4.5718901453958
Receivables turnover: 7.913019390581717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.59460555668221
FCF margin (%): 2.8075334313519567
Rule of 40 score: 2.8075334313519567
Financial ratios for FERG.L — annual report dated 2023-07-31
Total revenue: 29734000000
Gross profit: 9025000000
Operating income: 2784000000
Net income: 1889000000
Capital expenditures: 441000000
Operating cash flow: 2723000000
Depreciation & amortization: 321000000
Net tangible assets: 2013000000
Owner earnings: 1769000000
Return on net tangible assets (%): 87.87878787878788
Capex to operating income (%): 15.84051724137931
Buffett classification: The Great
Stock price: 1.5260256410256408
P/E ratio: 0.15667236381194768
Shares outstanding: 193937826
Book value: 5037000000
P/B ratio: 0.058756024467097316
Market cap (USD): 295954095.2407692
Debt to equity: 1.0438753226126662
Current ratio: 1.671946951556456
Quick ratio: 0.9539510038681157
Effective tax rate (%): 23.33603896103896
Interest coverage ratio: 15.130434782608695
COGS to revenue (%): 69.64754153494316
SG&A to revenue (%): 19.909867491760274
Free cash flow (dilution-adjusted): 2231000000
Buyback yield (%): 306.80433709197695
Retained earnings: 8557000000
Inventory turnover: 5.3127244740892765
Receivables turnover: 8.266333055323882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.351159488878373
FCF margin (%): 7.5031949956279
Revenue growth (%): 4.088776867604845
Rule of 40 score: 11.591971863232745